NCT01025635

Safety and Efficacy of Azelaic Acid Foam, 15% in Papulopustular Rosacea

Randomized, Double-blind, Vehicle-controlled, Multicenter, Parallel-group Study to Investigate Safety and Efficacy of Azelaic Acid Foam, 15% Topically Applied Twice Daily in Subjects With Papulopustular Rosacea

• Status: Completed
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 401 (actual)
• Sponsor: LEO Pharma · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

This study will investigate the safety and efficacy of a new formulation of an existing medication for the treatment of papulopustular rosacea. The study will test the active ingredient plus foam against foam alone.

Conditions

• Papulopustular Rosacea

Interventions

Type	Name	Description
DRUG	Azelaic acid foam 15%	Applied topically twice daily for 12 weeks
DRUG	Vehicle foam	Applied topically twice daily for 12 weeks

Timeline

• Start date: 2009-12-01
• Primary completion: 2010-08-01
• Completion: 2010-08-01
• First posted: 2009-12-03
• Last updated: 2020-03-31
• Results posted: 2013-07-01

Locations

20 sites across 1 country: United States